LogicBio Therapeutics (LOGC) Misses Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts LOGC Hot Sheet
Price: $7.06 --0%
EPS Growth %: +82.6%
Financial Fact:
Loss before taxes: -143.9K
Today's EPS Names:
CRMT, PXED, AEHR, More
EPS Growth %: +82.6%
Financial Fact:
Loss before taxes: -143.9K
Today's EPS Names:
CRMT, PXED, AEHR, More
Join SI Premium – FREE
LogicBio Therapeutics (NASDAQ: LOGC) reported Q3 EPS of ($0.07).
For earnings history and earnings-related data on LogicBio Therapeutics (LOGC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Reiterates Buy Rating on Targa Resources (TRGP) ahead of earnings
- Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
- Middleby Corp (MIDD) PT Lowered to $152 at KeyBanc
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
